Pharma Focus Asia
KP - Choose our fully recyclable blister films

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership to Commercialize VAZKEPA®

Tuesday, August 01, 2023

Amarin Corporation and Lotus Pharmaceuticals have entered into significant long-term exclusive partnership to distribute and commercialise VAZKEPA® (icosapent ethyl) in ten countries. 

As per the agreement between Amarin Corporation and Lotus Pharmaceuticals, Lotus will have exclusive rights to distribute and carry out commercial promotion for VAZKEPA® in South Korea and nine countries within the Association of Southeast Asian Nations (ASEAN). These countries include Brunei, Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam.

Under the terms of agreement, Amarin Corporation will receive an upfront payment, pricing and reimbursement benefits, and sales milestone payments. These payments will be based on the net sales of VAZKEPA® in the regions covered by the agreement.

VAZKEPA® capsules have received approval and have been successfully commercialised in various markets, including the United States and European countries as the first prescription treatment comprised solely of the active ingredient icosapent ethyl, which is a highly purified form of eicosapentaenoic acid (EPA).

This partnership agreement aims to bring innovative and transformative treatments to patients.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024